Tardive dyskinesia (TD) is a movement disorder marked by involuntary, repetitive motions that can appear after exposure to certain medications—most notably some drugs used for mental health conditions and nausea. The earliest signs can be easy to miss, especially when they resemble fidgeting or facial tics. This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

Warning signs people often miss

TD symptoms often develop gradually, and early movements may be brief or situational (for example, more noticeable during stress or when someone is concentrating). They can also be mistaken for dry mouth behaviors, anxiety-related habits, or normal restlessness. Warning signs that many people do not recognize include:

• Lip smacking, puckering, or chewing motions that happen without intention
• Tongue movements such as darting, rolling, or pressing against the inside of the cheeks
• Frequent blinking, grimacing, or subtle facial twitching
• Jaw clenching or side-to-side jaw movement not explained by dental issues
• Finger tapping, foot tapping, or toe movements that persist even at rest
• Shoulder shrugging or small trunk sways that feel “automatic”

Common risk factors and medication links

TD is most closely associated with long-term exposure to dopamine receptor–blocking medications, particularly antipsychotic medications. Risk is not identical for everyone, and TD can occur even when a medication is taken as prescribed. Common risk factors linked to TD include:

• Longer duration of exposure to antipsychotic medications (including older and newer agents)
• Higher cumulative dose over time (even if current dose is lower)
• Older age
• Female sex
• Mood disorders and certain other psychiatric conditions requiring ongoing treatment
• Diabetes and some other metabolic conditions
• Prior acute medication-related movement symptoms (such as drug-induced stiffness or tremor)

Medication changes should never be made abruptly or without medical supervision, because stopping or switching drugs too quickly can worsen underlying symptoms and may also affect movement patterns.

How involuntary movements may affect everyday life over time

Even when movements are mild, TD can influence daily functioning in practical and social ways. Facial and mouth movements may interfere with speaking clearly, chewing, or keeping dentures in place. Hand or foot movements can affect typing, handwriting, driving comfort, or the ability to sit through meetings. Over time, some people begin avoiding eye contact, social meals, or public settings due to self-consciousness, which can compound stress and fatigue.

Symptoms can fluctuate day to day. Some people notice that movements increase with anxiety, poor sleep, or caffeine, while others notice them more when they are relaxed because they are less distracted. This variability is one reason TD can go unrecognized for months.

Why early recognition and medical evaluation may be important

Early recognition helps clinicians document a clear timeline, review medication exposure, and distinguish TD from other conditions that can look similar (such as essential tremor, Parkinsonism, dystonia, or anxiety-related behaviors). A careful evaluation typically includes a medication history (including past drugs), a focused neurological exam, and sometimes standardized rating tools to track severity over time.

Prompt evaluation also supports safer decision-making. If a dopamine-blocking medication is still needed, clinicians may consider strategies such as adjusting dose, switching to an alternative with a different risk profile, or adding targeted treatments—balancing movement symptoms with mental health stability and overall quality of life.

Treatment approaches that may help manage symptoms

Some people first seek help through a primary care clinician or psychiatrist, while others benefit from evaluation by specialists who routinely assess complex movement symptoms. In the United States, the following health systems are well known for neurology and movement-disorder or multidisciplinary care that may include assessment for involuntary movements.

---

---

After diagnosis, treatment is usually individualized. Options may include reviewing the current medication plan (without abrupt changes), addressing contributing factors such as sleep problems or stress, and considering medications specifically approved to treat TD symptoms (often referred to as VMAT2 inhibitors). Some people also benefit from supportive approaches such as speech therapy for communication and swallowing concerns, occupational therapy for fine-motor challenges, and targeted strategies to reduce functional impact at work or at home.

Because TD can coexist with other medication-related movement symptoms, follow-up matters. Tracking patterns over time—what movements appear, when they worsen, and how they affect daily tasks—can help clinicians adjust the plan and monitor both symptom control and side effects.

A practical takeaway is that TD is not defined by a single dramatic symptom; it is often the accumulation of small, repetitive movements plus a relevant medication history. Recognizing subtle patterns, understanding risk factors, and seeking a timely clinical evaluation can support clearer diagnosis and more personalized symptom management over time.